Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Longitudinal tracking of spatial immune microenvironment and immune evasion in lung cancer

EF 2024-25

Résumé
Lung cancer is one of the most common cancers and a leading cause of cancer deaths worldwide. The body's immune system plays an important role in fighting cancer, but as lung cancer grows, it can develop ways to escape the immune system. This affects how fast the lung cancer grows and how easily it can come back after treatment. However, we still don't fully understand how the immune environment around the lung cancer cells at cancer diagnosis influences what happens when the cancer returns or spreads later in the disease. My research will explore how the immune system interacts with lung cancer over time, from the initial diagnosis to when the cancer comes back. I will use AI to analyze lung tissue samples to learn about the immune cells surrounding the cancer cells. Specifically, I will look at how lung cancer cells and certain immune cells interact with each other, and how these interactions explain why a cancer has spread. My goal is to uncover new insights into how cancer manipulates its surroundings to survive and spread. This research addresses the important question of how we can use information from the immune system to predict how lung cancer will progress. By identifying patterns in how the immune system interacts with lung cancer, this study could also lead to more effective therapies that prevent the cancer from returning or spreading. This would benefit lung cancer patients in Canada and around the world by improving survival rates and helping doctors select more personalized treatments that could be more effective for each individual patient. This study could also set a model for researchers tackling other cancer types, leading to a greater understanding of how we can mobilize the immune system to combat cancer.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
511941
Name
Liu Yiyang
Country
United Kingdom
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Longitudinal tracking of spatial immune microenvironment and immune evasion in lung cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Immunoediting; Intra-Tumour Heterogeneity; Lung Cancer; Tumour Evolution; Tumour Immune Microenvironment
Abstract
Lung cancer is one of the most common cancers and a leading cause of cancer deaths worldwide. The body's immune system plays an important role in fighting cancer, but as lung cancer grows, it can develop ways to escape the immune system. This affects how fast the lung cancer grows and how easily it can come back after treatment. However, we still don't fully understand how the immune environment around the lung cancer cells at cancer diagnosis influences what happens when the cancer returns or spreads later in the disease. My research will explore how the immune system interacts with lung cancer over time, from the initial diagnosis to when the cancer comes back. I will use AI to analyze lung tissue samples to learn about the immune cells surrounding the cancer cells. Specifically, I will look at how lung cancer cells and certain immune cells interact with each other, and how these interactions explain why a cancer has spread. My goal is to uncover new insights into how cancer manipulates its surroundings to survive and spread. This research addresses the important question of how we can use information from the immune system to predict how lung cancer will progress. By identifying patterns in how the immune system interacts with lung cancer, this study could also lead to more effective therapies that prevent the cancer from returning or spreading. This would benefit lung cancer patients in Canada and around the world by improving survival rates and helping doctors select more personalized treatments that could be more effective for each individual patient. This study could also set a model for researchers tackling other cancer types, leading to a greater understanding of how we can mobilize the immune system to combat cancer.
Competitiondate
202409
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Liu, Yiyang
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~